healthcare provider News
-
Showcase
PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear
Champaign, Ill. – Jan. 6, 2020 – PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing healthcare providers with better diagnostic tools, today announced that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for its TOMi™ Scope [OtoSight Middle Ear Scope] for non-invasive imaging of the middle ear. Using optical coherence ...
-
Candida auris and Infection Control Resources for Healthcare Providers
Candida auris is an emerging multidrug-resistant microorganism that was first identified in 2009 in Asia. It has quickly become a cause of severe infections around the world, including in the United States according to the Centers for Disease Control and Prevention (CDC). It is as yeast, which is a type of fungi. CDC describes Candida auris as a concerning drug-resistant fungus because it is: ...
-
New and Encouraging Global Diabetes Market Research Shows People with Diabetes are More Motivated to Manage their Condition than Healthcare Providers May Realize
Key Research Survey Findings: 52 percent of healthcare providers agreed motivation is a major barrier to patients adhering to blood glucose monitoring compared to only 10 percent of people with diabetes who agreed motivation is a major barrier. Healthcare providers claimed they are recommending blood glucose management apps to only 25 percent of their patients, while 55% of patients who ...
By LifeScan
-
Recruiting for COVID-19 study on stigma, fear, and misinformation
Looking for healthcare providers and policymakers! Consider participating in a research study with the Knowledge Translation Program to share your thoughts and perceptions on how stigma, fear and misinformation spreads during a pandemic or public health crisis. We are aiming to develop tools to combat stigma, fear and misinformation during the COVID-19 pandemic and other infectious disease ...
-
ATsens enters the UK NHS, the world`s largest public healthcare provider
ATsens is recently awarded by NHS Supply Chain as on of suppliers for long-term continuous ECG monitor 'AT-Patch'. It is believed to be recognition of new technology and competitiveness which can bring good value to NHS services. ATsens is now qualified to supply AT-Patch directly to NHS Trust Hospitals and its customers, around 1,978 NHS-registered bases. ...
-
Healthcare Providers in Puerto Rico Reminded of Fungal Infection Risks after Deaths at UPMC
Last week, a hospital in Pennsylvania temporarily stopped performing all transplants after several patients developed fungal infections. So far, three patients have died and one is still battling an infection. The Centers for Disease Control and Prevention (CDC) and the Pennsylvania Department of Health are now helping to investigate the cause of the outbreak. Healthcare-associated ...
-
Texas Healthcare Providers Reminded of Fungal Exposures Risks Following Deaths at Pennsylvania Hospital
Last week a Pittsburgh hospital that provides organ transplant services temporarily suspended future transplants to investigate an outbreak of fungal infections. To date one patient is fighting a fungal infection and three patients have died. The Centers for Disease Control and Prevention (CDC) and state health officials are reportedly now helping to investigate the source of the fungal ...
-
5 Challenges Facing UK Healthcare Organisations in 2024
As we look into the new year, the healthcare landscape in the UK is undergoing a number of changes. From digital transformation to evolving regulations, healthcare organisations across the UK are facing a number of challenges in 2024. We delve into five potential challenges confronting healthcare providers across the UK to help them prepare for the year ahead. ...
-
Medical Center Health System Selects UVDI’s UV Surface Disinfection Technology
Founded over 60 years ago, Medical Center Health System has grown from one facility into a family of healthcare providers delivering a broad range of advanced medical services to the people of Odessa, Texas and the surrounding 17 counties of the Permian Basin. Medical Center Hospital (MCH), a 402-bed regional medical center, currently serves over 100,000 patients each year. Recently, Medical ...
-
UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to creating novel solutions that treat urothelial and specialty cancers, today announced the first published report of real-world experience utilizing the antegrade approach for Jelmyto® (mitomycin) for pyelocalyceal solution administration in the Journal of Urology online on February 7, 2022. This report provides a stepwise ...
-
FDA Accepts Dupixent (dupilumab) for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) 300 mg weekly to treat adult and pediatric patients aged 12 years and older with eosinophilic esophagitis (EoE), a chronic and progressive type 2 inflammatory ...
-
Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. The CoviDx test gives qualified healthcare providers qualitative, easy-to-interpret results within 15-20 minutes in cases of suspected COVID-19 and when performing serial ...
-
Showcase
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
BOSTON, June 19, 2020 /PRNewswire/ -- Digital healthcare company Empatica announces a pioneering new partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), to validate an early warning system for COVID-19 and other respiratory ...
-
Glooko Webinar with Fierce Healthcare Covers Promising Outlook for Telehealth and Remote Patient Monitoring
Telehealth and remote patient monitoring (RPM) have been found to effectively manage patient and population health. During a webinar with Fierce Healthcare last month, Glooko CEO Russ Johannesson joined Tufia Haddad, MD, Chair of Practice Innovation and Platform, The Mayo Clinic and Professor Carri W. Chan, PhD, Professor, Division of Decision, Risk and Operations and Faculty Director, ...
By Glooko, Inc.
-
CD Formulation Provides Customization and Development Options for Shaped Healthcare Products
In the rapidly evolving landscape of healthcare, there is a growing demand for customized and innovative products to meet the specific needs of customers. CD Formulation, a leading company in the healthcare industry, is at the forefront of this evolution, providing cutting-edge solutions for the customization and development of shaped healthcare products. One of the standout features of CD ...
-
GE Healthcare Strengthens “Make in India” Capability for Accessible, Affordable Healthcare
Manufactures first ever India designed and developed Computed Tomography system – Revolution ACTs Announces a new venture GenWorks Health Pvt. Ltd to cater to the tier II/III towns GE Healthcare, a unit of General Electric Company (NYSE: GE), reiterated its commitment towards ‘Make in India’ by strengthening its R&D, Manufacturing, Supply Chain, Distribution ...
-
Coala Life intends to acquire Vitrics Management, a US company active in Remote Patient Monitoring
Coala-Life Group AB (publ), has today entered into an agreement to acquire 100 percent of the shares in Vitrics Management Group Inc (“Vitrics”) for a purchase price of USD 4.5 million on a cash and debt-free basis. Vitrics is a fast-growing service company in Remote Patient Monitoring (RPM). The acquisition is in line with Coala Life’s strategy, with clear sales synergies and ...
-
Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union. Dupixent is now also approved in children aged 6 to 11 years as an add-on maintenance treatment for severe asthma with type 2 inflammation characterized by raised blood eosinophils and/or raised ...
-
New Study Finds C. diff on a High Percentage of Healthcare Workers’ Hands
A new study has been published in the current issue of Infection Control and Hospital Epidemiology that found that almost a quarter of healthcare workers’ hands had Clostridium difficile (C. diff) spores on them following routine care of patients known to have the bacteria. This surprising figure brings to light the need to educate healthcare providers and the public about how this ...
-
Glycotest Update
NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic IP commercialisation group focused on healthcare, provides an update on the series A fundraising being undertaken by its portfolio company Glycotest, a US-based diagnostics company, as outlined in the Circular issued to shareholders following the Company’s placing and subscription of new shares on 26 May 2017 (the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you